Indosolar announces an acquisition
TL;DR
What is the specific share exchange ratio approved by the board, and what valuation methodology (e.g., DCF, comparable company analysis) was cited in the independent valuation report to justify the swap ratio between Indosolar and Waaree Energies?
The board-approved swap ratio was 1 equity share of Waaree Energies for every 11 equity shares of Indosolar held by public shareholders. [1]
The cited announcement extracts do not specify the independent valuation report’s methodology. They therefore do not establish whether the swap ratio was supported by a DCF, comparable-company analysis, net asset value, market-price method, or a combination of methods. [2]
So, the defensible answer is: ratio = 1:11; valuation methodology = not identified in the reported extracts.
Based on the pro-forma financials included in the scheme document, how does the amalgamation impact Indosolar’s existing debt obligations and accumulated losses, and what is the projected capacity utilization improvement for the combined entity’s solar cell manufacturing lines?
The quantitative impact cannot be established from the cited scheme extracts: the pro-forma balance sheet showing Indosolar’s debt and accumulated losses, and the capacity-utilization schedule for the combined entity, are not reproduced in the available material.
- Debt obligations: No scheme-level figure is available to show how Indosolar’s existing borrowings, interest obligations, or other liabilities would be assumed, refinanced, or eliminated after amalgamation. Indosolar’s FY26 standalone cash-flow extract does show net repayment of borrowings during the year, but that is historical cash-flow information—not the pro-forma post-amalgamation debt position.[3]
- Accumulated losses: The pro-forma adjustment to Indosolar’s accumulated losses and reserves is not reported in the cited extracts. Accordingly, it is not possible to determine whether the losses are carried into the combined entity, absorbed through accounting adjustments, or offset against other reserves.
- Capacity utilization: The available merger reporting says Indosolar did not have its own cell-production capacity and depended on Waaree for cells.[4] However, it does not state the pre- and post-amalgamation utilization rates or the projected percentage-point improvement for the combined solar-cell lines.
Implication: The merger appears operationally relevant because it would align Indosolar’s module business with Waaree’s cell-manufacturing base, but the debt clean-up, treatment of accumulated losses, and utilization uplift remain unquantifiable without the scheme’s pro-forma balance-sheet and manufacturing-capacity tables.
Beyond the board approval, what are the specific timelines and regulatory milestones (e.g., NCLT approval, SEBI/Stock Exchange observations, and creditor consent) outlined in the scheme document that must be met before the amalgamation becomes effective?
The disclosure sets out approval conditions, not fixed calendar deadlines. Beyond the board approval on 23 September 2026, the amalgamation cannot become effective until the following gates are cleared:
What is not specified: the disclosed material does not provide a dated sequence for exchange observations, a response period for SEBI or the stock exchanges, an NCLT sanction deadline, a creditor-consent deadline, or a long-stop date for completion. Accordingly, the transaction remains conditional on obtaining the listed approvals rather than being tied to a stated calendar timetable.
| Milestone | Requirement disclosed | Timeline or status |
|---|---|---|
| Board approval | Indosolar’s Board approved the draft scheme under Sections 230–232 of the Companies Act, 2013. | Completed on 23 September 2026 [5] |
| Stock-exchange filing | The scheme must be submitted to BSE and NSE. It will be made available on Indosolar’s website after that submission. | No submission deadline or review period is specified [5] |
| SEBI/listing-compliance process | The filing is to be made under the Listing Regulations and SEBI circular dated 20 June 2023. | The disclosure does not specify a separate SEBI approval date, observation timeline, or clearance deadline [5] |
| NCLT sanction | Approval from the jurisdictional National Company Law Tribunal is required. | No NCLT filing, hearing, or order deadline is stated [5] |
| Shareholder approval | Approval of the shareholders of the companies is required, where applicable. | No meeting date, voting threshold, or long-stop date is given [5] |
| Creditor consent | Approval of creditors is required, where applicable. | No creditor-consent deadline, creditor class, or voting threshold is specified [5] |
| Effectiveness | Once the scheme becomes effective, Indosolar will be dissolved without winding up. | The effective date itself is not provided [6] |
Sources
- [1]Indosolar board approves merger with Waaree Energies — Scanx, 2026-09-23T20:07:03.285066
- [2]Indosolar-Waaree merger: 1:11 swap and FY27 EBITDA — Multibagg, 2026-09-23T20:05:56.970894
- [3]INDOSOLAR - a WAAREE group company — Nsearchives, 2026-09-23T20:05:54.651311
- [4]India's Waaree Energies to merge Indosolar into company ... — Reuters, 2026-09-23T00:00:00
- [5]Board Approves Amalgamation of Indosolar with Waaree Energies, Details Scheme and Share Exchange Ratio — 2026-09-23T20:10:55, p.1
- [6]Board Approves Amalgamation of Indosolar with Waaree Energies, Details Scheme and Share Exchange Ratio — 2026-09-23T20:10:55, p.4
Keep digging
